| 1 |
35246337 | Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes. | 2022 Feb |
2 |
| 2 |
35498417 | Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population. | 2022 |
1 |
| 3 |
35571202 | Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism. | 2022 |
2 |
| 4 |
35600617 | Neuronal Dysfunction Is Linked to the Famine-Associated Risk of Proliferative Retinopathy in Patients With Type 2 Diabetes. | 2022 |
1 |
| 5 |
33326580 | High-sugar feeding and increasing cholesterol levels in infants. | 2021 Mar 21 |
1 |
| 6 |
33535788 | New Insight Into Metformin-Induced Cholesterol-Lowering Effect Crosstalk Between Glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Regulation. | 2021 Apr |
3 |
| 7 |
33801208 | PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy. | 2021 Mar 2 |
1 |
| 8 |
31835041 | Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. | 2020 Jan |
1 |
| 9 |
31963408 | Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients. | 2020 Jan 17 |
1 |
| 10 |
32032671 | Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients. | 2020 Nov |
2 |
| 11 |
32938225 | Hydrogen sulfide accumulates LDL receptor precursor via downregulating PCSK9 in HepG2 cells. | 2020 Dec 1 |
1 |
| 12 |
33142230 | Combined intake of glucose-and lipid-lowering medications further elevates plasma levels of PCSK9 in type 2 diabetes patients. | 2020 Nov-Dec |
6 |
| 13 |
33225229 | The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model. | 2020 Dec |
2 |
| 14 |
30899674 | C679X loss-of-function PCSK9 variant is associated with lower fasting glucose in black South African adolescents: Birth to Twenty Plus Cohort. | 2019 Jun |
1 |
| 15 |
30953636 | Keep recycling going: New approaches to reduce LDL-C. | 2019 Jun |
1 |
| 16 |
29180351 | Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. | 2018 Feb |
1 |
| 17 |
29343301 | Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population. | 2018 Jan 17 |
1 |
| 18 |
29946054 | Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance. | 2018 Aug |
1 |
| 19 |
30199407 | Key aspects of PCSK9 inhibition beyond LDL lowering. | 2018 Dec |
1 |
| 20 |
30227170 | C679X loss-of-function PCSK9 variant lowers fasting glucose levels in a black South African population: A longitudinal study. | 2018 Oct |
1 |
| 21 |
27908689 | PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. | 2017 Feb |
2 |
| 22 |
28012395 | Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells. | 2017 Feb |
1 |
| 23 |
28093849 | Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women. | 2017 Dec |
1 |
| 24 |
28128061 | The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins. | 2017 |
4 |
| 25 |
28179493 | Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors. | 2017 Apr |
1 |
| 26 |
28447578 | Proprotein Convertase Subtilisin/Kexin type 9 affects insulin but not lipid metabolism in cystic fibrosis. | 2017 Apr 26 |
3 |
| 27 |
28587771 | Hypercholesterolemia: The role of PCSK9. | 2017 Jul 1 |
1 |
| 28 |
28762908 | [Blood Levels of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Men from Different Population Groups and Its Relation to Unfavorable Long-Term Prognosis]. | 2017 Apr |
1 |
| 29 |
28782494 | The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review. | 2017 |
5 |
| 30 |
29081489 | PCSK9 rs7552841 is associated with plasma lipids profiles in female Chinese adolescents without posttraumatic stress disorder. | 2017 Nov 20 |
1 |
| 31 |
29088858 | Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. | 2017 Sep 26 |
2 |
| 32 |
29242844 | Effects of increased body weight and short-term weight loss on serum PCSK9 levels - a prospective pilot study. | 2017 |
1 |
| 33 |
26377225 | Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes. | 2016 Feb |
2 |
| 34 |
26743379 | Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders. | 2016 Mar-Apr |
1 |
| 35 |
27488210 | Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases. | 2016 Aug 4 |
1 |
| 36 |
27658826 | Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease. | 2016 Sep 22 |
1 |
| 37 |
27888904 | [Anti-PCSK9 antibodies in type 2 diabetes and secondary prevention of cardiovascular diseases]. | 2016 May |
1 |
| 38 |
25649668 | Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk. | 2015 Jun |
1 |
| 39 |
26003826 | Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status. | 2015 Dec |
1 |
| 40 |
26176608 | Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. | 2015 |
1 |
| 41 |
22460556 | Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels. | 2012 Jun |
1 |
| 42 |
19571328 | A new method for measurement of total plasma PCSK9: clinical applications. | 2010 Jan |
1 |
| 43 |
21040917 | Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population. | 2010 Dec |
1 |
| 44 |
19351729 | Genetic and metabolic determinants of plasma PCSK9 levels. | 2009 Jul |
1 |
| 45 |
19628659 | Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescents. | 2009 Sep |
1 |
| 46 |
19768174 | Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels. | 2009 |
1 |